Study Presented at 44th Annual Meeting of Society of Toxicology -

UC-II(TM), InterHealth Nutraceuticals' undenatured type II collagen, significantly reduced both pain and lameness associated with arthritis in a four month study conducted on dogs at Murray State University Veterinary College, Hopkinsville, KY. The study also showed that a combination of UC-II and glucosamine plus chondroitin sulfate provided significantly better results than glucosamine plus chondroitin sulfate alone, suggesting that a formulation of these ingredients could provide enhanced benefits to joint health sufferers.

UC-II is a patented nutritional ingredient manufactured by InterHealth Nutraceuticals of Benicia, California. It is the only source of undenatured type II collagen available as a dietary supplement. UC-II differs from denatured or hydrolyzed type II collagen in that protein structure of the collagen is not broken down, which is key to its effectiveness.

Results of the study were presented at the 44th annual meeting of the Society of Toxicology in New Orleans, March 6-10. The study, entitled "Efficacy and Safety of Glycosylated Undenatured Type II Collagen (UC-II) in Therapy of Arthritic Dogs," has also been accepted for publication in the Journal of Veterinary Pharmacology and Therapeutics.

"This study provides strong evidence that UC-II can provide significant help for those suffering from joint health problems," stated Dr. Ramesh Gupta, professor and head of toxicology and veterinary medicine who led the research team. "It also shows that UC-II can significantly enhance the effects of glucosamine plus chondroitin sulfate in arthritis sufferers."

Large breed dogs, which commonly experience arthritis due to obesity, injury, age and immune disorders, were divided into three groups. The control group received no supplementation, while Group 1 received one milligram of UC-II per day and Group 2 received 10 milligrams per day (the recommended human dosage). Those that received UC-II showed a marked decline in pain and lameness after physical exertion, with the 10 milligram dose being the most effective. Neither dose produced any side effects or changes in serum chemistry, and was well-tolerated.

"This research provides further evidence that UC-II can provide significant relief for the 43 million Americans who suffer from joint health problems," stated William "Skip" Seroy, president of InterHealth Nutraceuticals. "We are especially gratified by the research showing that UC-II can compliment and enhance the benefits derived from the widely used chondroitin sulfate and glucosamine."

UC-II, made by InterHealth Nutraceuticals, is the only source of undenatured type II collagen available in the marketplace. It is protected by U.S. Patents 5,645,851, 5,637,321, 5,529,786, and 5,750,144; worldwide patents are pending. UC-II is available in products sold in natural health stores and on the Internet. Consumers can identify these products by looking for the UC-II logo on the label.

About InterHealth Nutraceuticals Inc.

InterHealth Nutraceuticals researches, develops, markets and distributes specialty nutritional ingredients, which are sold worldwide to manufacturers of dietary supplements and nutraceutical food and beverage products. In addition to UC-II, the company's products include Super CitriMax(R), Aller-7(R), OptiBerry(R), ChromeMate(R), L-OptiZinc(R) and Protykin(R). For more information about the InterHealth and its products, call 1-800-783-4636 or 1-707-751-2800 (outside U.S.) or visit the website at http://www.interhealthusa.com.

InterHealth Nutraceuticals, Inc.
http://www.interhealthusa.com